Literature DB >> 26946987

Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.

Ellen S Haddock1, Antoanella Calame2, Chisato Shimizu3, Adriana H Tremoulet3, Jane C Burns3, Wynnis L Tom4.   

Abstract

BACKGROUND: A psoriasis-like eruption develops in a subset of patients with Kawasaki disease (KD).
OBJECTIVE: We sought to systematically compare KD-associated psoriasiform eruptions with classic psoriasis and the outcomes of KD in children with and without this rash.
METHODS: This was a retrospective study of 11 KD cases with a psoriasiform eruption matched 1:2 by age, gender, and ethnicity with psoriasis-only and KD-only controls. Genotyping was performed in 10 cases for a deletion of 2 late cornified envelope (LCE) genes, LCE3C_LCE3B-del, associated with increased risk for pediatric-onset psoriasis.
RESULTS: Similar to classic psoriasis, KD-associated eruptions were characterized clinically by well-demarcated, scaly pink plaques and histopathologically by intraepidermal neutrophils, suprabasilar keratin 16 expression, and increased Ki-67 expression. They showed less frequent diaper area involvement, more crust and serous exudate, and an enduring remission (91% vs 23% with confirmed resolution; P < .001). Frequency of LCE3C_LCE3B-del and major KD outcomes were similar between cases and controls. LIMITATIONS: The study was limited by the small number of cases, treatment variation, and availability of skin biopsy specimens.
CONCLUSIONS: Although the overall clinical and histopathologic findings were similar to conventional psoriasis, this appears to be a distinct phenotype with significantly greater propensity for remission. No adverse effect on KD outcomes was noted.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kawasaki disease; Ki-67; LCE3C_LCE3B deletion; keratin 16; psoriasiform; psoriasis

Mesh:

Substances:

Year:  2016        PMID: 26946987      PMCID: PMC4912865          DOI: 10.1016/j.jaad.2016.02.1146

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  22 in total

1.  Guttate psoriasis following Kawasaki disease.

Authors:  B Garty; R Mosseri; Y Finkelstein
Journal:  Pediatr Dermatol       Date:  2001 Nov-Dec       Impact factor: 1.588

2.  Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06.

Authors:  J G M Bergboer; A M Oostveen; M E A de Jager; M den Heijer; I Joosten; P C M van de Kerkhof; P L J M Zeeuwen; E M G J de Jong; J Schalkwijk; M M B Seyger
Journal:  Br J Dermatol       Date:  2012-10       Impact factor: 9.302

3.  Immunohistological detection of proliferating cells in normal and psoriatic epidermis using Ki-67 monoclonal antibody.

Authors:  M Ando; T Kawashima; H Kobayashi; A Ohkawara
Journal:  J Dermatol Sci       Date:  1990-11       Impact factor: 4.563

Review 4.  Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications.

Authors:  J M Carrascosa; V Rocamora; R M Fernandez-Torres; R Jimenez-Puya; J C Moreno; N Coll-Puigserver; E Fonseca
Journal:  Actas Dermosifiliogr       Date:  2012-11-23

5.  A comparative study of pediatric onset psoriasis with adult onset psoriasis.

Authors:  S P Raychaudhuri; J Gross
Journal:  Pediatr Dermatol       Date:  2000 May-Jun       Impact factor: 1.588

6.  Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California.

Authors:  Jashin J Wu; Mary Helen Black; Ning Smith; Amy H Porter; Steven J Jacobsen; Corinna Koebnick
Journal:  J Am Acad Dermatol       Date:  2011-02-08       Impact factor: 11.527

Review 7.  Antimicrobial peptides in the pathogenesis of psoriasis.

Authors:  Shin Morizane; Richard L Gallo
Journal:  J Dermatol       Date:  2012-03       Impact factor: 4.005

8.  Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Authors:  Adriana H Tremoulet; Sonia Jain; Preeti Jaggi; Susan Jimenez-Fernandez; Joan M Pancheri; Xiaoying Sun; John T Kanegaye; John P Kovalchin; Beth F Printz; Octavio Ramilo; Jane C Burns
Journal:  Lancet       Date:  2014-02-24       Impact factor: 79.321

Review 9.  Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.

Authors:  Uwe Wollina; Gesina Hansel; André Koch; Jaqueline Schönlebe; Erich Köstler; Gunter Haroske
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

Review 10.  Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.

Authors:  Stephanie Bayers; Stanford T Shulman; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2013-10       Impact factor: 11.527

View more
  5 in total

1.  Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.

Authors:  Sara E Vazquez; Sabrina A Mann; Aaron Bodansky; Andrew F Kung; Zoe Quandt; Elise M N Ferré; Nils Landegren; Daniel Eriksson; Paul Bastard; Shen-Ying Zhang; Jamin Liu; Anthea Mitchell; Caleigh Mandel-Brehm; Brenda Miao; Gavin Sowa; Kelsey Zorn; Alice Y Chan; Chisato Shimizu; Adriana Tremoulet; Kara Lynch; Michael R Wilson; Olle Kampe; Kerry Dobbs; Ottavia M Delmonte; Luigi D Notarangelo; Jane C Burns; Jean-Laurent Casanova; Michail S Lionakis; Troy R Torgerson; Mark S Anderson; Joseph L DeRisi
Journal:  bioRxiv       Date:  2022-03-24

Review 2.  Kawasaki disease for dermatologists.

Authors:  Aman Gupta; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

3.  Cyclosporine for refractory Kawasaki disease with psoriasiform eruption.

Authors:  Mara Leyendecker; Brian Wanner; Brad Hammon; Guliz Erdem; Bonita Fung; Esteban Fernandez Faith
Journal:  JAAD Case Rep       Date:  2021-02-17

4.  A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report.

Authors:  Thabitha Jebaseeli Hoole; Arjuna Salinda Athapathu; Anoma Damayanthi Abeygunawardene
Journal:  BMC Pediatr       Date:  2022-07-23       Impact factor: 2.567

Review 5.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.